|
Volumn 47, Issue 3, 2001, Pages 294-297
|
Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer;Znachenie opukholevogo markera CA 19-9 i kartsino-émbrional'nogo antigena (KEA) v diagnostike, vybore lechebnoi taktiki i prognozirovanii raka podzheludochnoi zhelezy.
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
TUMOR MARKER;
ARTICLE;
BLOOD;
CANCER STAGING;
DIFFERENTIAL DIAGNOSIS;
HUMAN;
IMMUNOLOGY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PANCREAS TUMOR;
PATHOLOGY;
PREDICTION AND FORECASTING;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
SURVIVAL;
CA-19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
COMBINED MODALITY THERAPY;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
NEOPLASM STAGING;
PANCREATIC NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0035225070
PISSN: 05073758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|